ArticleAnnals of internal medicine2022

In patients with COVID-19 at risk for severe disease, nirmatrelvir + ritonavir reduced hospitalization or death.

Athanasios Vassilopoulos et al.PubMed ↗Publisher ↗

No numbers read from the abstract.